HY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Hyster-Yale Inc is not a strong buy for a beginner investor with a long-term strategy at this moment. While there are some positive catalysts, such as a potential recovery in bookings and an analyst upgrade, the company's financial performance remains weak, with significant losses and declining revenue. Technical indicators and options data do not signal a compelling entry point, and there is no strong trading signal from Intellectia Proprietary Trading Signals. Holding off on this investment until clearer signs of recovery and growth emerge would be prudent.
The MACD is negatively expanding, RSI is neutral at 48.039, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 36.877, with resistance at 40.082 and support at 33.672. Overall, the technical indicators suggest a lack of strong momentum in either direction.
Analyst upgrade to 'Outperform' with a $50 price target.
Sequential and year-over-year increase in Q4 2025 bookings, signaling potential demand recovery.
Improved operating cash flow of $57 million in Q4 2025.
Q4 2025 revenue declined by 13.52% YoY to $923 million.
Significant net loss of $52.5 million in Q4 2025, with an annual loss of $60.1 million for
EPS dropped to -$2.96, down 610.34% YoY.
Gross margin decreased by 27.04% YoY to 14.19%.
The company's Q4 2025 financials show a revenue decline of 13.52% YoY, a net loss of $52.5 million, and a significant drop in EPS to -$2.96. Gross margin also fell by 27.04% YoY to 14.19%, reflecting weak financial performance overall.
Northland upgraded Hyster-Yale to 'Outperform' from 'Market Perform' with a $50 price target, citing confidence in a second-half 2026 recovery in lift-truck shipments. This indicates optimism about the company's future performance despite current challenges.
